Plasma von Willebrand factor-collagen binding activity in normal dogs and in dogs with von Willebrand's disease.
A sensitive enzyme-linked immunosorbent assay was used for the simultaneous assessment of the amount of von Willebrand factor (vWF) in canine plasma and its ability to bind to canine collagen in vitro. In 60 normal dogs, there was close correlation between the concentration of vWF and its activity as determined by vWF-collagen binding. In 14 dogs with type I expressions of von Willebrand's disease, the ratio of vWF antigen to collagen binding activity was normal or only slightly increased. In 7 dogs with type II expressions of the disease, this ratio was consistently elevated suggesting a significant functional deficiency of the protein. Plasma from 3 dogs with type III von Willebrand's disease had little collagen binding activity because of the severe quantitative deficiency of the protein. The described assay permits the rapid assessment of both the quantity and quality of vWF in a dog. This information is necessary for the detection and characterization of canine von Willebrand's disease, particularly the type II expressions, which cannot be diagnosed by quantitative vWF assays alone.
Johnstone
I B
IB
Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Canada.
D000818:Animals; D003094:Collagen / Q000378:metabolism*; D004283:Dog Diseases / Q000097:blood*; D004285:Dogs / Q000097:blood*; D007700:Kinetics; D011485:Protein Binding; D012016:Reference Values; D014842:von Willebrand Diseases / Q000097:blood / Q000662:veterinary*; D014841:von Willebrand Factor / Q000378:metabolism*
D014841:von Willebrand Factor; D003094:Collagen